Trial Profile
Tolerability and pharmacokinetics of multiple escalating doses of apremilast in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Apr 2012
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Ankylosing spondylitis; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Celgene Corporation
- 18 Apr 2012 Results published in the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 18 Apr 2012 New trial record